Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes

IMPORTANCE: Postmenopausal individuals with type 2 diabetes are susceptible to fractures due to the interaction of elevated blood glucose levels and a deficiency of the hormone estrogen. Despite continued concerns of fracture risks associated with sodium-glucose cotransporter 2 inhibitors (SGLT2i),...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Hwa Yeon, Bea, Sungho, Jeong, Han Eol, Park, Sohee, Cho, Young Min, Kong, Sung Hye, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523172/
https://www.ncbi.nlm.nih.gov/pubmed/37751205
http://dx.doi.org/10.1001/jamanetworkopen.2023.35797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523172/
https://www.ncbi.nlm.nih.gov/pubmed/37751205
http://dx.doi.org/10.1001/jamanetworkopen.2023.35797

Ejemplares similares